Navigating Securities Fraud Class Actions: Protecting Investor Losses in enCore Energy and Geron Cases

Investors holding shares in enCore Energy Corp. (NASDAQ: EU) and Geron Corporation (NASDAQ: GERN) face critical deadlines in May 2025 to join ongoing securities fraud class actions. Missing these dates could permanently forfeit their right to seek compensation for losses caused by alleged corporate misstatements. As the clock ticks toward May 12 (Geron) and May 13 (enCore), the stakes could not be higher for shareholders who failed to act. This article dissects the risks of delayed action, the legal landscape, and the broader lessons for evaluating corporate transparency.

Geron Corporation: A Case of Downplayed Risks and Sharply Falling Shares

Geron’s class action centers on allegations that executives misled investors about the growth potential of its cancer drug Rytelo (imetelstat). According to the lawsuit, the company downplayed critical risks, including the burden of weekly patient monitoring, seasonal sales fluctuations, and competition. These omissions, plaintiffs argue, artificially inflated GERN’s stock price until February 26, 2025, when Geron disclosed that Rytelo’s sales had stagnated. The revelation sent shares plummeting by 32%, from $2.37 to $1.61—a stark illustration of the consequences of corporate opacity.

With the May 12 deadline looming, GERN investors who held shares between February 28, 2024, and February 25, 2025, must act swiftly. Failing to join the class action by this date means surrendering the right to recover losses. Law firms like The Gross Law Firm and Faruqi & Faruqi are actively seeking clients, emphasizing that participation incurs no upfront cost.

enCore Energy: Accounting Irregularities and Eroded Trust

enCore’s case revolves around alleged failures to disclose material weaknesses in its financial reporting. The lawsuit claims the company misrepresented its ability to capitalize exploratory costs under GAAP, leading to inflated revenue figures and artificially buoyant stock prices. When these issues came to light in March 2025, the fallout sent EU’s stock into a tailspin.

Shareholders who owned EU shares between March 28, 2024, and March 2, 2025, now have until May 13 to join the class action. The deadline applies not only to joining the case but also to seeking lead plaintiff status—a designation that carries influence over litigation strategy. Law firms such as Holzer & Holzer and The Gross Law Firm are urging affected investors to act promptly.

The Peril of Delay: Why Missing Deadlines Is Irrevocable

Legal deadlines in securities fraud cases are non-negotiable. Once the clock expires, investors lose their standing to participate in any settlement or judgment. For Geron and enCore, the narrow one-day gap between the two deadlines (May 12 vs. May 13) creates a high-pressure environment. Even a single day’s delay could mean permanent exclusion.

The risks extend beyond financial loss. Missing deadlines undermines the collective power of shareholders to hold companies accountable. Class actions rely on broad participation to demonstrate the scale of harm—a critical factor in settlement negotiations.

Broader Implications: A Wake-Up Call for Investor Due Diligence

These cases underscore the fragility of trust in corporate disclosures. Both Geron and enCore faced allegations of omitting material risks that directly impacted their products’ viability and financial health. For investors, the message is clear: due diligence must extend beyond earnings reports to scrutinize qualitative factors like regulatory hurdles, competitive threats, and accounting practices.

The legal actions also highlight the importance of monitoring corporate communications for inconsistencies. Geron’s sudden revelation about Rytelo’s sales challenges, for instance, should have raised red flags for investors attuned to seasonal trends and market competition.

Call to Action: Don’t Let Time Run Out

For investors in GERN and EU, the path forward is clear:

1. Verify Holdings: Confirm if you owned shares during the class periods (Feb 28, 2024 – Feb 25, 2025 for GERN; Mar 28, 2024 – Mar 2, 2025 for EU).
2. Act by the Deadline: Contact a law firm by May 12 (GERN) or May 13 (EU) to submit a claim.
3. Seek Lead Plaintiff Status: Those with significant losses may want to pursue leadership roles in the case.

The stakes are not just financial but foundational. By acting now, shareholders send a message that corporate transparency and accountability are non-negotiable.

In a market where trust is hard-won and easily lost, these deadlines are more than bureaucratic formalities—they are a lifeline for investors seeking justice. The clock is ticking.